My random blood glucose is 320 mg/dL while I am taking insulin and metformin; what should I do?

Immediate Management of Random Blood Glucose 320 mg/dL on Insulin and Metformin

Your random glucose of 320 mg/dL while already on insulin and metformin signals complete inadequacy of your current regimen and requires immediate aggressive intensification—not minor adjustments—to prevent acute complications and long-term damage.

---

Immediate Actions (Next 24–48 Hours)

Check for Diabetic Ketoacidosis

• Test urine or blood ketones immediately, especially if you experience nausea, vomiting, abdominal pain, or confusion; glucose > 300 mg/dL with ketones indicates early DKA requiring urgent medical evaluation. 1
• If ketones are present (urine ≥ trace or blood ≥ 0.5 mmol/L), contact your physician or go to the emergency department without delay. 1

Verify Insulin Potency and Administration

• Inspect your insulin vial for clumping, frosting, precipitation, or color changes—any of these indicate loss of potency and require replacement. 1
• Confirm you drew the correct dose and injected subcutaneously (not intramuscularly); improper technique prevents expected glucose lowering. 1
• Replace any insulin vial that has been in use > 1 month at room temperature or exposed to extreme temperatures (< 36°F or > 86°F). 1

Immediate Correction Dose

• Administer 4 units of rapid-acting insulin (lispro, aspart, or glulisine) immediately for a glucose of 320 mg/dL; this is the standard correction for pre-meal glucose > 250 mg/dL. 1, 2
• Recheck glucose 1–2 hours after the correction dose; if glucose remains > 300 mg/dL after 2 hours, give an additional correction dose and investigate underlying causes. 1

---

Why Your Current Regimen Is Failing

Sliding-Scale Insulin Is Condemned as Monotherapy

• If you are relying solely on correction (sliding-scale) insulin without scheduled basal and prandial doses, major diabetes guidelines explicitly condemn this approach because it reacts to hyperglycemia rather than preventing it, causing dangerous glucose fluctuations. 1, 2
• Only ≈ 38 % of patients achieve mean glucose < 140 mg/dL with sliding-scale alone, versus ≈ 68 % with a scheduled basal-bolus regimen. 1, 2

Inadequate Basal Insulin Coverage

• A glucose of 320 mg/dL indicates your basal insulin dose is profoundly insufficient to suppress hepatic glucose production between meals and overnight. 1, 2
• Increase your basal insulin by 4 units every 3 days until fasting glucose consistently reaches 80–130 mg/dL; this aggressive titration is required for glucose ≥ 180 mg/dL. 1, 3

Missing Prandial (Mealtime) Insulin

• A random glucose of 320 mg/dL demonstrates complete lack of mealtime insulin coverage; you need scheduled rapid-acting insulin before each of your three largest meals, not just correction doses. 1, 2
• Begin with 4 units of rapid-acting insulin before each meal (or ≈ 10 % of your current basal dose), administered 0–15 minutes before eating. 1, 3

---

Required Regimen Restructuring

Discontinue Sliding-Scale Monotherapy

• Stop using correction-only insulin as your sole regimen immediately; transition to a scheduled basal-bolus approach with correction doses used only as supplements. 1, 2

Basal Insulin Titration

• Increase your basal insulin by 4 units every 3 days until fasting glucose is 80–130 mg/dL; do not wait for your next appointment to make these adjustments. 1, 3
• If any glucose reading falls < 70 mg/dL, reduce the implicated insulin dose by 10–20 % immediately and treat with 15 g of fast-acting carbohydrate. 1, 3
• Stop basal escalation when your dose approaches 0.5 units/kg/day (roughly 35–50 units for most adults); beyond this threshold, add prandial insulin rather than further basal increases to avoid "over-basalization." 1, 3

Initiate Scheduled Prandial Insulin

• Start 4 units of rapid-acting insulin before breakfast, lunch, and dinner; this provides the mealtime coverage your current regimen lacks. 1, 3
• Increase each meal dose by 1–2 units every 3 days based on your 2-hour post-meal glucose, targeting < 180 mg/dL. 1, 3
• Administer prandial insulin 0–15 minutes before meals for optimal post-meal control. 1, 3

Correction Insulin Protocol (Adjunct Only)

• Add 2 units of rapid-acting insulin for pre-meal glucose > 250 mg/dL and 4 units for > 350 mg/dL, in addition to your scheduled prandial dose—never as a replacement. 1, 2

---

Metformin Optimization

Maximize Metformin Dose

• Increase metformin to at least 2000 mg daily (1000 mg twice daily with meals) unless contraindicated; this is the optimal therapeutic dose that provides maximal glucose-lowering effect. 1, 2
• Metformin reduces total insulin requirements by 20–30 % and yields superior glycemic control when combined with insulin. 1, 2
• Never discontinue metformin when intensifying insulin unless you have specific contraindications (renal impairment with eGFR < 30 mL/min, acute infection, or tissue hypoxia). 1, 2

Metformin's Mechanisms

• Metformin lowers glucose by suppressing hepatic gluconeogenesis, reducing hepatic glucose output, and enhancing insulin-stimulated glucose uptake into skeletal muscle—effects that complement insulin therapy. 4
• It improves insulin sensitivity by increasing insulin receptor tyrosine kinase activity and activating post-receptor signaling pathways, directly addressing insulin resistance. 4

---

Monitoring Requirements

Daily Glucose Checks During Titration

• Check fasting glucose every morning to guide basal insulin adjustments. 1, 3
• Measure glucose before each meal to calculate correction doses. 1, 3
• Obtain 2-hour post-meal glucose after each meal to assess prandial insulin adequacy. 1, 3
• Record bedtime glucose to evaluate overall daily pattern. 1, 3

HbA1c Reassessment

• Recheck HbA1c in exactly 3 months; this is the longest acceptable interval before assessing effectiveness and avoiding therapeutic inertia. 1

---

Expected Clinical Outcomes

Glycemic Control

• With properly implemented basal-bolus therapy, ≈ 68 % of patients achieve mean glucose < 140 mg/dL, compared with ≈ 38 % on inadequate regimens. 1, 2
• You can expect HbA1c reduction of 2–3 % (or 3–4 % if your HbA1c is ≥ 9 %) within 3–6 months of intensive insulin titration combined with metformin. 1, 5

Hypoglycemia Risk

• Properly executed basal-bolus regimens do not increase overall hypoglycemia incidence compared with inadequate sliding-scale approaches. 1, 2

---

Critical Pitfalls to Avoid

Do Not Delay Insulin Intensification

• Do not wait for your next appointment when glucose is 320 mg/dL; prolonged hyperglycemia increases complication risk and requires immediate action. 1, 5

Do Not Continue Sliding-Scale Monotherapy

• Never rely solely on correction doses without scheduled basal and prandial insulin; this reactive strategy is unsafe and ineffective. 1, 2

Do Not Discontinue Metformin

• Never stop metformin when intensifying insulin unless contraindicated; omission raises insulin needs by 20–30 % and worsens outcomes. 1, 2

Do Not Use Rapid-Acting Insulin at Bedtime Alone

• Avoid giving rapid-acting insulin at bedtime as a sole correction dose; this markedly raises nocturnal hypoglycemia risk. 1, 3

---

When to Seek Urgent Medical Care

Emergency Department Criteria

• Presence of ketones (≥ trace urine or ≥ 0.5 mmol/L blood) with glucose > 300 mg/dL. 1
• Nausea, vomiting, abdominal pain, or altered mental status. 1
• Persistent glucose > 300 mg/dL despite two correction doses. 1
• Inability to take oral fluids or evidence of dehydration. 1

Urgent Provider Contact

• Glucose remains > 180 mg/dL after 2–3 weeks of aggressive basal titration. 1, 3
• Any glucose reading < 70 mg/dL without obvious cause. 1, 3

---

Alternative to Further Prandial Insulin: GLP-1 Receptor Agonist

When to Consider GLP-1 RA

• If your basal insulin exceeds 0.5 units/kg/day without achieving targets, adding a GLP-1 receptor agonist (e.g., semaglutide, liraglutide, dulaglutide) instead of prandial insulin provides comparable post-prandial control with less hypoglycemia and weight loss rather than weight gain. 1, 5
• GLP-1 RAs provide an additional 0.6–0.8 % HbA1c reduction when combined with metformin and basal insulin. 1, 5

---

Your glucose of 320 mg/dL is a medical emergency requiring immediate aggressive insulin intensification, not minor adjustments. Implement the basal-bolus regimen outlined above, maximize metformin to 2000 mg daily, and monitor glucose at least four times daily during titration. Contact your physician today to formalize this plan and ensure proper follow-up.